| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Kintara Therapeutics Inc (NASDAQ: KTRA)
KTRA Technical Analysis
4
| As on 9th Jun 2023 KTRA STOCK Price closed @ 3.34 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.46 & Strong Buy for SHORT-TERM with Stoploss of 0.46 we also expect STOCK to react on Following IMPORTANT LEVELS. |
KTRASTOCK Price
| Open | 3.31 | Change | Price | % |
| High | 3.48 | 1 Day | -0.04 | -1.18 |
| Low | 3.31 | 1 Week | 0.31 | 10.23 |
| Close | 3.34 | 1 Month | 0.38 | 12.84 |
| Volume | 5321 | 1 Year | 2.71 | 430.16 |
| 52 Week High 14.80 | 52 Week Low 0.09 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| KTRA Daily Charts |
KTRA Intraday Charts |
Whats New @ Bazaartrend |
KTRA Free Analysis |
|
|
KTRA Important Levels Intraday
| RESISTANCE | 3.67 |
| RESISTANCE | 3.56 |
| RESISTANCE | 3.50 |
| RESISTANCE | 3.43 |
| SUPPORT | 3.25 |
| SUPPORT | 3.18 |
| SUPPORT | 3.12 |
| SUPPORT | 3.01 |
KTRA Forecast May 2024
| 4th UP Forecast | 3.78 |
| 3rd UP Forecast | 3.64 |
| 2nd UP Forecast | 3.55 |
| 1st UP Forecast | 3.47 |
| 1st DOWN Forecast | 3.21 |
| 2nd DOWN Forecast | 3.13 |
| 3rd DOWN Forecast | 3.04 |
| 4th DOWN Forecast | 2.9 |
KTRA Weekly Forecast
| 4th UP Forecast | 3.59 |
| 3rd UP Forecast | 3.51 |
| 2nd UP Forecast | 3.46 |
| 1st UP Forecast | 3.41 |
| 1st DOWN Forecast | 3.27 |
| 2nd DOWN Forecast | 3.22 |
| 3rd DOWN Forecast | 3.17 |
| 4th DOWN Forecast | 3.09 |
KTRA Forecast2024
| 4th UP Forecast | 33.04 |
| 3rd UP Forecast | 23.51 |
| 2nd UP Forecast | 17.63 |
| 1st UP Forecast | 11.74 |
| 1st DOWN Forecast | -5.06 |
| 2nd DOWN Forecast | -10.95 |
| 3rd DOWN Forecast | -16.83 |
| 4th DOWN Forecast | -26.36 |
Kintara Therapeutics Inc ( NASDAQ USA Symbol : KTRA )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
KTRA Business Profile
Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme, as well as other solid tumors, including ovarian cancer, non-small cell lung cancer, and diffuse intrinsic pontine glioma; and REM-001, a photodynamic therapy for the treatment of cutaneous metastatic breast cancer. The company has a strategic collaboration with Guangxi Wuzhou Pharmaceutical (Group) Co. Ltd. to manufacture and sell VAL-083 in China. The company was formerly known as DelMar Pharmaceuticals, Inc. and changed its name to Kintara Therapeutics, Inc. in August 2020. Kintara Therapeutics, Inc. was incorporated in 2009 and is headquartered in San Diego, California. Address: 12707 High Bluff Drive, San Diego, CA, United States, 92130
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service